BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 19933848)

  • 1. Cdk2 and Cdk4 regulate the centrosome cycle and are critical mediators of centrosome amplification in p53-null cells.
    Adon AM; Zeng X; Harrison MK; Sannem S; Kiyokawa H; Kaldis P; Saavedra HI
    Mol Cell Biol; 2010 Feb; 30(3):694-710. PubMed ID: 19933848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cdk2 and Cdk4 activities are dispensable for tumorigenesis caused by the loss of p53.
    Padmakumar VC; Aleem E; Berthet C; Hilton MB; Kaldis P
    Mol Cell Biol; 2009 May; 29(10):2582-93. PubMed ID: 19307310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mammalian in vitro centriole duplication system: evidence for involvement of CDK2/cyclin E and nucleophosmin/B23 in centrosome duplication.
    Tarapore P; Okuda M; Fukasawa K
    Cell Cycle; 2002 Jan; 1(1):75-81. PubMed ID: 12429912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin-dependent kinase 2 is dispensable for normal centrosome duplication but required for oncogene-induced centrosome overduplication.
    Duensing A; Liu Y; Tseng M; Malumbres M; Barbacid M; Duensing S
    Oncogene; 2006 May; 25(20):2943-9. PubMed ID: 16331279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RABL6A, a novel RAB-like protein, controls centrosome amplification and chromosome instability in primary fibroblasts.
    Zhang X; Hagen J; Muniz VP; Smith T; Coombs GS; Eischen CM; Mackie DI; Roman DL; Van Rheeden R; Darbro B; Tompkins VS; Quelle DE
    PLoS One; 2013; 8(11):e80228. PubMed ID: 24282525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lats1 suppresses centrosome overduplication by modulating the stability of Cdc25B.
    Mukai S; Yabuta N; Yoshida K; Okamoto A; Miura D; Furuta Y; Abe T; Nojima H
    Sci Rep; 2015 Nov; 5():16173. PubMed ID: 26530630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional relationship among PLK2, PLK4 and ROCK2 to induce centrosome amplification.
    Ling H; Hanashiro K; Luong TH; Benavides L; Fukasawa K
    Cell Cycle; 2015; 14(4):544-53. PubMed ID: 25590559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between ROCK II and nucleophosmin/B23 in the regulation of centrosome duplication.
    Ma Z; Kanai M; Kawamura K; Kaibuchi K; Ye K; Fukasawa K
    Mol Cell Biol; 2006 Dec; 26(23):9016-34. PubMed ID: 17015463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific phosphorylation of nucleophosmin on Thr(199) by cyclin-dependent kinase 2-cyclin E and its role in centrosome duplication.
    Tokuyama Y; Horn HF; Kawamura K; Tarapore P; Fukasawa K
    J Biol Chem; 2001 Jun; 276(24):21529-37. PubMed ID: 11278991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated ROCK II by-passes the requirement of the CDK2 activity for centrosome duplication and amplification.
    Hanashiro K; Brancaccio M; Fukasawa K
    Oncogene; 2011 May; 30(19):2188-97. PubMed ID: 21242972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct regulation of the centrosome duplication cycle by the p53-p21Waf1/Cip1 pathway.
    Tarapore P; Horn HF; Tokuyama Y; Fukasawa K
    Oncogene; 2001 May; 20(25):3173-84. PubMed ID: 11423967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDK4 inhibition restores G(1)-S arrest in MYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage.
    Gogolin S; Ehemann V; Becker G; Brueckner LM; Dreidax D; Bannert S; Nolte I; Savelyeva L; Bell E; Westermann F
    Cell Cycle; 2013 Apr; 12(7):1091-104. PubMed ID: 23462184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice thrive without Cdk4 and Cdk2.
    Barrière C; Santamaría D; Cerqueira A; Galán J; Martín A; Ortega S; Malumbres M; Dubus P; Barbacid M
    Mol Oncol; 2007 Jun; 1(1):72-83. PubMed ID: 19383288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ECRG2 disruption leads to centrosome amplification and spindle checkpoint defects contributing chromosome instability.
    Cheng X; Shen Z; Yang J; Lu SH; Cui Y
    J Biol Chem; 2008 Feb; 283(9):5888-98. PubMed ID: 18162463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Cdk2 activity decreases Aurora-A kinase centrosomal localization and prevents centrosome amplification in breast cancer cells.
    Leontovich AA; Salisbury JL; Veroux M; Tallarita T; Billadeau D; McCubrey J; Ingle J; Galanis E; D'Assoro AB
    Oncol Rep; 2013 May; 29(5):1785-8. PubMed ID: 23446853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of cyclins A and E in induction of centrosome amplification in p53-compromised cells.
    Hanashiro K; Kanai M; Geng Y; Sicinski P; Fukasawa K
    Oncogene; 2008 Sep; 27(40):5288-302. PubMed ID: 18490919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of nucleophosmin in centrosome duplication.
    Okuda M
    Oncogene; 2002 Sep; 21(40):6170-4. PubMed ID: 12214246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication.
    Okuda M; Horn HF; Tarapore P; Tokuyama Y; Smulian AG; Chan PK; Knudsen ES; Hofmann IA; Snyder JD; Bove KE; Fukasawa K
    Cell; 2000 Sep; 103(1):127-40. PubMed ID: 11051553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct evidence for the role of centrosomally localized p53 in the regulation of centrosome duplication.
    Shinmura K; Bennett RA; Tarapore P; Fukasawa K
    Oncogene; 2007 May; 26(20):2939-44. PubMed ID: 17072342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-κB induces abnormal centrosome amplification by upregulation of CDK2 in laryngeal squamous cell cancer.
    Liu JL; Ma HP; Lu XL; Sun SH; Guo X; Li FC
    Int J Oncol; 2011 Oct; 39(4):915-24. PubMed ID: 21769424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.